婴儿早期核酸检测诊断围产期获得性丙型肝炎病毒感染
本研究基于美国全国儿童医院2008年至2018年的电子健康记录,评估2-6月龄婴儿HCV-RNA RT-PCR诊断围产期HCV感染的性能。770例暴露婴儿中28例(3.6%)阳性,早期HCV-RNA检测灵敏度100%(87.5-100%,95%CI)和特异度100%(98.3-100%),提示现代HCV-RNA检测可辅助早期诊断。
要点
- 2-6月龄HCV-RNA检测灵敏度100%、特异度100%,可早期识别围产期感染。
- 暴露婴儿中仅3.6%早期RNA阳性,多数阴性者仍需随访至18月龄后抗体检测。
- 现代HCV-RNA RT-PCR有望改善因18月龄后失访导致的筛查不足。
核心结论
- 现代HCV-RNA RT-PCR对围产期获得性HCV感染的早期诊断具有极好的灵敏度。
- 鉴于18月龄后大量失访,早期HCV-RNA检测可辅助HCV监测。
研究设计与样本
- 回顾性队列研究,基于美国全国儿童医院2008年1月1日至2018年6月30日电子健康记录。
- 纳入2-6月龄接受HCV-RNA RT-PCR检测的围产期HCV暴露婴儿770例。
主要发现
- 770例暴露婴儿中28例(3.6%)HCV-RNA阳性,重复检测的27例均确认病毒血症。
- 742例HCV-RNA阴性婴儿中226例在≥18月龄接受抗-HCV随访,223例阴性。
- 3例在18-24月龄抗-HCV低滴度阳性,24月龄后复测阴性,可能提示母体抗体衰减。
关键数值与推荐
- 早期HCV-RNA筛查灵敏度100%(87.5-100%,Wilson-Brown 95%CI)。
- 早期HCV-RNA筛查特异度100%(98.3-100%,Wilson-Brown 95%CI)。
临床怎么用
- 可考虑在2-6月龄采用HCV-RNA RT-PCR早期诊断围产期HCV感染,以弥补18月龄后抗体检测失访。
- HCV-RNA阴性婴儿仍需按指南在≥18月龄完成抗-HCV检测以确认未感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most US children with perinatal hepatitis C virus (HCV) exposure fail to receive the recommended anti-HCV antibody test at age ≥18 months. Earlier testing for viral RNA might facilitate increased screening, but sensitivity of this approach has not been established. We hypothesized that modern HCV-RNA RT-PCR platforms would adequately detect infected infants. METHODS: Nationwide Children's Hospital electronic health records from 1/1/2008 to 30/6/2018 were reviewed to identify perinatally exposed infants tested by HCV-RNA RT-PCR at age 2-6 months. Diagnostic performance was determined using a composite case definition: (1) infected children had positive repeat HCV-RNA testing or positive anti-HCV at age ≥24 months; (2) uninfected children lacked these criteria and had negative anti-HCV at age ≥18 months. RESULTS: 770 perinatally exposed infants underwent HCV-RNA testing at age 2-6 months. Of these, 28 (3.6%) tested positive; viremia was confirmed in all who underwent repeat testing (n = 27). Among 742 infants with negative HCV-RNA results, 226 received follow-up anti-HCV testing at age ≥18 months, of whom 223 tested negative. Three children had low-positive anti-HCV results at age 18-24 months that were negative upon retesting after age 24 months, possibly indicating waning maternal antibodies. Using the composite case definitions, early HCV-RNA screening demonstrated sensitivity of 100% (87.5-100%, Wilson-Brown 95% CI) and specificity of 100% (98.3-100%). CONCLUSIONS: Modern HCV-RNA RT-PCR assays have excellent sensitivity for early diagnosis of perinatally acquired infection and could aid HCV surveillance given the substantial loss to follow-up at ≥18 months of age.
引用
- Gowda C, Smith S, Crim L, et al. Nucleic Acid Testing for Diagnosis of Perinatally Acquired Hepatitis C Virus Infection in Early Infancy. Clin Infect Dis. 2021. PMID: 32640018. doi:10.1093/cid/ciaa949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。